CEO of DNAS
Ann Arbor, MI – Dr. John SantaLucia, Jr. has been named President and CEO of DNA Software, Inc.
Dr. SantaLucia’s appointment follows former CEO Donald Hicks.
Dr. SantaLucia, a world-renowned expert in nucleic acid chemistry, most recently served as Chief Scientific Officer at DNAS. He helped to co-found DNA Software in 2000 to commercialize the advances in nucleic acid thermodynamics discovered throughout his illustrious career, which includes citation in more than 4000 publications. Dr. SantaLucia’s published thermodynamic parameters for nucleic acid hybridization are widely used throughout the field. As a result of Dr. SantaLucia’s expertise and influence, DNA Software’s technologies have become the standard of excellence for nucleic acid research and diagnostics development.
Dr. SantaLucia holds a B.S. in Chemistry from Clarkson University, a PhD from the University of Rochester and completed his postdoctoral work at the University of California at Berkeley.
About DNA Software, Inc.
DNA Software, Inc. provides the most accurate and comprehensive software tools for assay development and nucleic acid research. DNA Software serves such customers as the CDC, USDA, FDA, Roche, Novartis, Johnson & Johnson, Smiths Detection, and Luminex amongst many other leaders in the life sciences.
DNA Software is a unique software company considering that it conducts original wet lab research. The company’s software programs are the most accurate and comprehensive tools available because their advanced algorithms and models are driven by a large database of thousands of diverse, wet lab-derived, experimental results. DNA Software’s tools correctly design and simulate complicated experiments on the first attempt. Customers can simulate thousands of experiments with the software before running a single experiment in a wet lab. Thus, DNA Software’s technologies save customers significant time, resources, and money that would have been wasted on trial-and-error experimentation.
DNA Software offers contract research, custom software development, commercial web applications, and scientific consulting for nucleic acid research. The company also licenses packaged software tools that help scientists quickly and accurately develop new assays, diagnostics, and therapeutics. The company has recently expanded its original DNA and RNA-based, molecular biology solutions to include modified nucleotides, oligonucleotide kinetics, and structural biology.